Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 2,728 | 887 | 546 | 715 | 1,425 |
| Gross Profit | 2,728 | 887 | 546 | 715 | 1,425 |
| Operating Expenses | 15,595 | 13,876 | 12,390 | 12,972 | 19,366 |
| Operating Income | -12,867 | -12,989 | -11,844 | -12,257 | -17,941 |
| Other Income | 242 | 2,542 | 431 | 478 | 702 |
| Pre-tax Income | -12,625 | -10,447 | -11,413 | -11,779 | -17,239 |
| Net Income Continuous | -12,625 | -10,447 | -11,413 | -11,779 | -17,239 |
| Net Income | $-12,625 | $-10,447 | $-11,413 | $-11,779 | $-17,239 |
| EPS Basic Total Ops | -0.73 | -0.52 | -0.75 | -0.84 | -1.40 |
| EPS Basic Continuous Ops | -0.73 | -0.51 | -0.75 | -0.84 | -1.40 |
| EPS Diluted Total Ops | -0.73 | -0.52 | -0.75 | -0.84 | -1.40 |
| EPS Diluted Continuous Ops | -0.73 | -0.51 | -0.75 | -0.84 | -1.40 |
| EBITDA(a) | $-11,765 | $-12,004 | $-10,964 | $-11,411 | $-16,934 |